Randal W. Scott, Director at BridgeBio Pharma, Inc. (BBIO), sold 2,500 shares at $29.48 ($76K) on 2024-06-03, disclosed to the SEC on 2024-06-05.
Scheduled sale ($76k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.68 | 800 | $23K | 30.3% |
| 2 | $29.48 | 200 | $6K | 7.8% |
| 3 | $31.30 | 1,500 | $47K | 61.9% |
| Total | $30.32 avg | 2,500 | $76K | 100% |
| Filing → |
| BBIO | SELL | 2025-11-19 | $1.3M | — | Filing → |
| BBIO | SELL | 2024-03-05 | $85K | — | Filing → |
| BBIO | SELL | 2023-12-20 | $80K | — | Filing → |